This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
8/5/2024
Helen
Executive (specific role not provided)
pipeline for this disease are affecting just the downstream inflammation. So we expect to see healing of the skin and improvement of the disease from that perspective, as well as preventing then the downstream inflammation that causes other effects in the disease.
Jim Stonehouse
CEO
And one of the things you see in rare diseases like this where there's nothing to treat it is there are way more patients than you originally estimated, and that's really exciting as well.
Moderator
Conference Moderator
Thank you. The next question comes from Gina Wang with Barclays. Please go ahead.
You're reading a preview of the BCRX Q2 2024 earnings call.
Free account.
Disclaimer